{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:26:22Z","timestamp":1788452782266,"version":"build-2803163510"},"reference-count":119,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T00:00:00Z","timestamp":1653782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Gilead Sciences","award":["10150511910052"],"award-info":[{"award-number":["10150511910052"]}]},{"name":"Gilead Sciences","award":["AI159085"],"award-info":[{"award-number":["AI159085"]}]},{"name":"Gilead Sciences","award":["NS105699"],"award-info":[{"award-number":["NS105699"]}]},{"name":"Gilead Sciences","award":["NS091263"],"award-info":[{"award-number":["NS091263"]}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["10150511910052"],"award-info":[{"award-number":["10150511910052"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["AI159085"],"award-info":[{"award-number":["AI159085"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["NS105699"],"award-info":[{"award-number":["NS105699"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["NS091263"],"award-info":[{"award-number":["NS091263"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institutes of Health","award":["10150511910052"],"award-info":[{"award-number":["10150511910052"]}]},{"name":"National Institutes of Health","award":["AI159085"],"award-info":[{"award-number":["AI159085"]}]},{"name":"National Institutes of Health","award":["NS105699"],"award-info":[{"award-number":["NS105699"]}]},{"name":"National Institutes of Health","award":["NS091263"],"award-info":[{"award-number":["NS091263"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Measles virus (MV) is a highly contagious respiratory virus responsible for outbreaks associated with significant morbidity and mortality among children and young adults. Although safe and effective measles vaccines are available, the COVID-19 pandemic has resulted in vaccination coverage gaps that may lead to the resurgence of measles when restrictions are lifted. This puts individuals who cannot be vaccinated, such as young infants and immunocompromised individuals, at risk. Therapeutic interventions are complicated by the long incubation time of measles, resulting in a narrow treatment window. At present, the only available WHO-advised option is treatment with intravenous immunoglobulins, although this is not approved as standard of care. Antivirals against measles may contribute to intervention strategies to limit the impact of future outbreaks. Here, we review previously described antivirals and antiviral assays, evaluate the antiviral efficacy of a number of compounds to inhibit MV dissemination in vitro, and discuss potential application in specific target populations. We conclude that broadly reactive antivirals could strengthen existing intervention strategies to limit the impact of measles outbreaks.<\/jats:p>","DOI":"10.3390\/v14061186","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T05:25:42Z","timestamp":1653974742000},"page":"1186","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Repurposing an In Vitro Measles Virus Dissemination Assay for Screening of Antiviral Compounds"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8537-0646","authenticated-orcid":false,"given":"Katharina S.","family":"Schmitz","sequence":"first","affiliation":[{"name":"Department of Viroscience, Erasmus MC, 3015 GD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona V.","family":"Lange","sequence":"additional","affiliation":[{"name":"Department of Viroscience, Erasmus MC, 3015 GD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennert","family":"Gommers","sequence":"additional","affiliation":[{"name":"Department of Viroscience, Erasmus MC, 3015 GD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Handrejk","sequence":"additional","affiliation":[{"name":"Department of Viroscience, Erasmus MC, 3015 GD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle P.","family":"Porter","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Foster City, CA 94404, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2654-018X","authenticated-orcid":false,"given":"Christopher A.","family":"Alabi","sequence":"additional","affiliation":[{"name":"Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY 14850, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Moscona","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Columbia University Medical Center, New York, NY 10032, USA"},{"name":"Center for Host\u2013Pathogen Interaction, Columbia University Irving Medical Center, New York, NY 10032, USA"},{"name":"Department of Physiology and Cellular Biophysics, Columbia University Irving Medical Center, New York, NY 10032, USA"},{"name":"Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY 10032, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Porotto","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Columbia University Medical Center, New York, NY 10032, USA"},{"name":"Center for Host\u2013Pathogen Interaction, Columbia University Irving Medical Center, New York, NY 10032, USA"},{"name":"Department of Experimental Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, 81100 Caserta, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2817-0127","authenticated-orcid":false,"given":"Rory D.","family":"de Vries","sequence":"additional","affiliation":[{"name":"Department of Viroscience, Erasmus MC, 3015 GD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3599-8969","authenticated-orcid":false,"given":"Rik L.","family":"de Swart","sequence":"additional","affiliation":[{"name":"Department of Viroscience, Erasmus MC, 3015 GD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,29]]},"reference":[{"key":"ref_1","unstructured":"Measles & Rubella Initiative (2022, February 20). Measles & Rubella Strategic Framework 2021\u20142030. Available online: https:\/\/measlesrubellainitiative.org\/measles-rubella-strategic-framework-2021-2030\/."},{"key":"ref_2","unstructured":"WHO (2022, February 20). Measles Fact Sheet. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/measles."},{"key":"ref_3","unstructured":"WHO (2022, February 20). Worldwide Measles Deaths Climb 50% from 2016 to 2019 Claiming over 207,500 Lives in 2019. Available online: https:\/\/www.who.int\/news\/item\/12-11-2020-worldwide-measles-deaths-climb-50-from-2016-to-2019-claiming-over-207-500-lives-in-2019."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.15585\/mmwr.mm7045a1","article-title":"Progress toward Regional Measles Elimination\u2014Worldwide, 2000\u20132020","volume":"70","author":"Dixon","year":"2021","journal-title":"Morb. Mortal Wkly. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"n2755","DOI":"10.1136\/bmj.n2755","article-title":"Measles outbreaks likely as covid pandemic leaves millions of world\u2019s children unvaccinated, WHO warns","volume":"375","author":"Torjesen","year":"2021","journal-title":"BMJ"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1099\/jgv.0.001328","article-title":"ICTV Virus Taxonomy Profile: Paramyxoviridae","volume":"100","author":"Rima","year":"2019","journal-title":"J. Gen. Virol."},{"key":"ref_7","unstructured":"WHO (2015). Genetic diversity of wild-type measles viruses and the global measles nucleotide surveillance database (MeaNS). Wkly. Epidemiol. Rec., 90, 373\u2013380."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S514","DOI":"10.1093\/infdis\/jir118","article-title":"Global Distribution of Measles Genotypes and Measles Molecular Epidemiology","volume":"204","author":"Rota","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1099\/0022-1317-67-9-1987","article-title":"Transcriptional map of the measles virus genome","volume":"67","author":"Dowling","year":"1986","journal-title":"J. Gen. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1006\/viro.1996.0060","article-title":"Domains of the Measles Virus N Protein Required for Binding to P Protein and Self-Assembly","volume":"216","author":"Bankamp","year":"1996","journal-title":"Virology"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Plattet, P., Alves, L., Herren, M., and Aguilar, H.C. (2016). Measles Virus Fusion Protein: Structure, Function and Inhibition. Viruses, 8.","DOI":"10.3390\/v8040112"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1128\/JVI.75.13.5842-5850.2001","article-title":"Morbilliviruses Use Signaling Lymphocyte Activation Molecules (CD150) as Cellular Receptors","volume":"75","author":"Tatsuo","year":"2001","journal-title":"J. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature10639","article-title":"Adherens junction protein nectin-4 is the epithelial receptor for measles virus","volume":"480","author":"Mateo","year":"2011","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Noyce, R.S., Bondre, D.G., Ha, M.N., Lin, L.T., Sisson, G., Tsao, M.S., and Richardson, C.D. (2011). Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1002240"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"10374","DOI":"10.1128\/JVI.01056-09","article-title":"The Matrix Protein of Measles Virus Regulates Viral RNA Synthesis and Assembly by Interacting with the Nucleocapsid Protein","volume":"83","author":"Iwasaki","year":"2009","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.coviro.2017.05.004","article-title":"Structure and organization of paramyxovirus particles","volume":"24","author":"Cox","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0168-1702(95)00067-Z","article-title":"Protein interactions entered into by the measles virus P, V, and C proteins","volume":"38","author":"Liston","year":"1995","journal-title":"Virus Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.1016\/S1473-3099(17)30307-9","article-title":"The basic reproduction number (R0) of measles: A systematic review","volume":"17","author":"Guerra","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Lemon, K., de Vries, R.D., Mesman, A.W., McQuaid, S., van Amerongen, G., Y\u00fcksel, S., Ludlow, M., Rennick, L.J., Kuiken, T., and Rima, B.K. (2011). Early target cells of measles virus after aerosol infection of non-human primates. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1001263"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"De Swart, R.L., Ludlow, M., de Witte, L., Yanagi, Y., van Amerongen, G., McQuaid, S., Y\u00fcksel, S., Geijtenbeek, T.B., Duprex, W.P., and Osterhaus, A.D. (2007). Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog., 3.","DOI":"10.1371\/journal.ppat.0030178"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1128\/JVI.02633-09","article-title":"In vivo tropism of attenuated and pathogenic measles virus expressing green fluorescent protein in macaques","volume":"84","author":"Lemon","year":"2010","journal-title":"J. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1099\/vir.0.016428-0","article-title":"Wild-type measles virus infection of primary epithelial cells occurs via the basolateral surface without syncytium formation or release of infectious virus","volume":"91","author":"Ludlow","year":"2010","journal-title":"J. Gen. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1217378","article-title":"An Exit Strategy for Measles Virus","volume":"334","author":"Racaniello","year":"2011","journal-title":"Science"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"De Vries, R.D., McQuaid, S., van Amerongen, G., Y\u00fcksel, S., Verburgh, R.J., Osterhaus, A.D., Duprex, W.P., and de Swart, R.L. (2012). Measles immune suppression: Lessons from the macaque model. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002885"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1126\/science.aaa3662","article-title":"Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality","volume":"348","author":"Mina","year":"2015","journal-title":"Science"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Morris, S.E., Yates, A.J., de Swart, R.L., de Vries, R.D., Mina, M.J., Nelson, A.N., Lin, W.-H.W., Kouyos, R.D., Griffin, D.E., and Grenfell, B.T. (2018). Modeling the measles paradox reveals the importance of cellular immunity in regulating viral clearance. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1007493"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Laksono, B.M., Fortugno, P., Nijmeijer, B.M., de Vries, R.D., Cordisco, S., Kuiken, T., Geijtenbeek, T.B.H., Duprex, W.P., Brancati, F., and de Swart, R.L. (2020). Measles skin rash: Infection of lymphoid and myeloid cells in the dermis precedes viral dissemination to the epidermis. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008253"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ferren, M., Horvat, B., and Mathieu, C. (2019). Measles Encephalitis: Towards New Therapeutics. Viruses, 11.","DOI":"10.3390\/v11111017"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00430-016-0451-4","article-title":"Eradication of measles: Remaining challenges","volume":"205","author":"Holzmann","year":"2016","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Young, M.K., Nimmo, G.R., Cripps, A.W., and Jones, M.A. (2014). Post-exposure passive immunisation for preventing measles. Cochrane Database Syst. Rev., Cd010056.","DOI":"10.1002\/14651858.CD010056.pub2"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/rmv.480","article-title":"Convalescent whole blood, plasma and serum in the prophylaxis of measles: Reproduced from JAMA, 12 April 1926; 1180\u20131187","volume":"15","author":"Zingher","year":"2005","journal-title":"Rev. Med. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"7916","DOI":"10.1016\/j.vaccine.2018.10.070","article-title":"Post-exposure prophylaxis for measles with immunoglobulins revised recommendations of the standing committee on vaccination in Germany","volume":"36","author":"Santibanez","year":"2018","journal-title":"Vaccine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.antiviral.2004.01.003","article-title":"Improved antiviral activity in vitro of ribavirin against measles virus after complexation with cyclodextrins","volume":"62","author":"Grancher","year":"2004","journal-title":"Antivir. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1016\/S0960-894X(02)00762-X","article-title":"In vitro inhibition of the measles virus by novel ring-expanded (\u2018fat\u2019) nucleoside analogues containing the imidazo[4,5-e]diazepine ring system","volume":"12","author":"Zhang","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/infdis\/138.2.249","article-title":"In vitro inhibition of subacute sclerosing panencephalitis virus by the antiviral agent ribavirin","volume":"138","author":"Murphy","year":"1978","journal-title":"J. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0166-3542(89)90072-7","article-title":"Inhibitory effect of selected antiviral compounds on measles (SSPE) virus replication in vitro","volume":"12","author":"Hosoya","year":"1989","journal-title":"Antivir. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0166-3542(97)00055-7","article-title":"The cooperative effect of interferon-alpha and ribavirin on subacute sclerosing panencephalitis (SSPE) virus infections, in vitro and in vivo","volume":"37","author":"Takahashi","year":"1998","journal-title":"Antivir. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3851\/IMP2564","article-title":"Antivirally active ribavirin analogues\u20144,5-disubstituted 1,2,3-triazole nucleosides: Biological evaluation against certain respiratory viruses and computational modelling","volume":"23","author":"Krajczyk","year":"2014","journal-title":"Antivir. Chem. Chemother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1128\/AAC.36.2.435","article-title":"Antiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6\u2032-(R)-6\u2032-C-methylneplanocin A against several ortho- and paramyxoviruses","volume":"36","author":"Shigeta","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0166-3542(83)90011-6","article-title":"Broad-spectrum antiviral activity of the carbocyclic analog of 3-deazaadenosine","volume":"3","author":"Montgomery","year":"1983","journal-title":"Antivir. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"43395","DOI":"10.1038\/srep43395","article-title":"GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses","volume":"7","author":"Lo","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Lo, M.K., Shrivastava-Ranjan, P., Chatterjee, P., Flint, M., Beadle, J.R., Valiaeva, N., Schooley, R.T., Hostetler, K.Y., Montgomery, J.M., and Spiropoulou, C. (2021). Broad-spectrum in vitro antiviral activity of ODBG-P-RVn: An orally-available, lipid-modified monophosphate prodrug of remdesivir parent nucleoside (GS-441524). bioRxiv.","DOI":"10.1101\/2021.08.06.455494"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"154","DOI":"10.7883\/yoken.JJID.2020.481","article-title":"Antiviral Effect of Favipiravir (T-705) against Measles and Subacute Sclerosing Panencephalitis Viruses","volume":"74","author":"Hashimoto","year":"2021","journal-title":"Jpn. J. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1128\/AAC.00709-16","article-title":"Antiviral Activity of Favipiravir (T-705) against a Broad Range of Paramyxoviruses In Vitro and against Human Metapneumovirus in Hamsters","volume":"60","author":"Jochmans","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.antiviral.2018.03.009","article-title":"Susceptibility of paramyxoviruses and filoviruses to inhibition by 2\u2032-monofluoro- and 2\u2032-difluoro-4\u2032-azidocytidine analogs","volume":"153","author":"Lo","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/095632020101200405","article-title":"Inhibition of measles virus replication by 5\u2019-nor carbocyclic adenosine analogues","volume":"12","author":"Barnard","year":"2001","journal-title":"Antivir. Chem. Chemother."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1021\/jm301778x","article-title":"Novel antiviral activity of l-dideoxy bicyclic nucleoside analogues versus vaccinia and measles viruses in vitro","volume":"56","author":"McGuigan","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1128\/AAC.00503-09","article-title":"Target analysis of the experimental measles therapeutic AS-136A","volume":"53","author":"Yoon","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1021\/jm201699w","article-title":"Non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase: Synthesis, structure-activity relationships, and pharmacokinetics","volume":"55","author":"Ndungu","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"232ra252","DOI":"10.1126\/scitranslmed.3008517","article-title":"An orally available, small-molecule polymerase inhibitor shows efficacy against a lethal morbillivirus infection in a large animal model","volume":"6","author":"Krumm","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Cox, R.M., Sourimant, J., Govindarajan, M., Natchus, M.G., and Plemper, R.K. (2021). Therapeutic targeting of measles virus polymerase with ERDRP-0519 suppresses all RNA synthesis activity. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009371"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1038\/s41467-021-25497-4","article-title":"Small-molecule polymerase inhibitor protects non-human primates from measles and reduces shedding","volume":"12","author":"Wittwer","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/s41564-020-0752-7","article-title":"Orally efficacious broad-spectrum allosteric inhibitor of paramyxovirus polymerase","volume":"5","author":"Cox","year":"2020","journal-title":"Nat. Microbiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0042-6822(80)90168-3","article-title":"Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides","volume":"105","author":"Richardson","year":"1980","journal-title":"Virology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0005-2760(90)90165-T","article-title":"Effect of drugs which inhibit cholesterol synthesis on syncytia formation in vero cells infected with measles virus","volume":"1042","author":"Malvoisin","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e01026-17","DOI":"10.1128\/JVI.01026-17","article-title":"Mutations in the Fusion Protein of Measles Virus That Confer Resistance to the Membrane Fusion Inhibitors Carbobenzoxy-d-Phe-l-Phe-Gly and 4-Nitro-2-Phenylacetyl Amino-Benzamide","volume":"91","author":"Ha","year":"2017","journal-title":"J. Virol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1128\/AAC.49.9.3755-3761.2005","article-title":"Design of a small-molecule entry inhibitor with activity against primary measles virus strains","volume":"49","author":"Plemper","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1073\/pnas.1718957115","article-title":"Structures of the prefusion form of measles virus fusion protein in complex with inhibitors","volume":"115","author":"Hashiguchi","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Watanabe, M., Hashimoto, K., Abe, Y., Kodama, E.N., Nabika, R., Oishi, S., Ohara, S., Sato, M., Kawasaki, Y., and Fujii, N. (2016). A Novel Peptide Derived from the Fusion Protein Heptad Repeat Inhibits Replication of Subacute Sclerosing Panencephalitis Virus In Vitro and In Vivo. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0162823"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"13785","DOI":"10.1128\/JVI.02436-13","article-title":"Fatal measles virus infection prevented by brain-penetrant fusion inhibitors","volume":"87","author":"Welsch","year":"2013","journal-title":"J. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1128\/JVI.02417-14","article-title":"Prevention of measles virus infection by intranasal delivery of fusion inhibitor peptides","volume":"89","author":"Mathieu","year":"2015","journal-title":"J. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e01554-16","DOI":"10.1128\/JVI.01554-16","article-title":"In Vivo Efficacy of Measles Virus Fusion Protein-Derived Peptides Is Modulated by the Properties of Self-Assembly and Membrane Residence","volume":"91","author":"Figueira","year":"2017","journal-title":"J. Virol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e01862-18","DOI":"10.1128\/JVI.01862-18","article-title":"Measles Virus Bearing Measles Inclusion Body Encephalitis-Derived Fusion Protein Is Pathogenic after Infection via the Respiratory Route","volume":"93","author":"Mathieu","year":"2019","journal-title":"J. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"12794","DOI":"10.1021\/acsnano.1c02057","article-title":"Inhibition of Measles Viral Fusion Is Enhanced by Targeting Multiple Domains of the Fusion Protein","volume":"15","author":"Bovier","year":"2021","journal-title":"ACS Nano"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1021\/jm0602559","article-title":"Nonpeptide inhibitors of measles virus entry","volume":"49","author":"Sun","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1128\/AAC.00289-07","article-title":"Nonnucleoside inhibitor of measles virus RNA-dependent RNA polymerase complex activity","volume":"51","author":"White","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/JVI.01826-12","article-title":"Mechanism for active membrane fusion triggering by morbillivirus attachment protein","volume":"87","author":"Ader","year":"2013","journal-title":"J. Virol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1073\/pnas.0308520101","article-title":"A target site for template-based design of measles virus entry inhibitors","volume":"101","author":"Plemper","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"9423","DOI":"10.1128\/JVI.00846-09","article-title":"Clearance of measles virus from persistently infected cells by short hairpin RNA","volume":"83","author":"Zinke","year":"2009","journal-title":"J. Virol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e0262121","DOI":"10.1128\/mBio.02621-21","article-title":"Highly Potent Host-Specific Small-Molecule Inhibitor of Paramyxovirus and Pneumovirus Replication with High Resistance Barrier","volume":"12","author":"Shrestha","year":"2021","journal-title":"mBio"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1021\/ml400166b","article-title":"Synthesis and Metabolic Studies of Host Directed Inhibitors for Anti Viral Therapy","volume":"4","author":"Moore","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/095632020201300105","article-title":"Antiviral activity of brassinosteroids derivatives against measles virus in cell cultures","volume":"13","author":"Wachsman","year":"2002","journal-title":"Antivir. Chem. Chemother."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Mor\u00e1n-Santiba\u00f1ez, K., Pe\u00f1a-Hern\u00e1ndez, M.A., Cruz-Su\u00e1rez, L.E., Ricque-Marie, D., Skouta, R., Vasquez, A.H., Rodr\u00edguez-Padilla, C., and Trejo-Avila, L.M. (2018). Virucidal and Synergistic Activity of Polyphenol-Rich Extracts of Seaweeds against Measles Virus. Viruses, 10.","DOI":"10.3390\/v10090465"},{"key":"ref_74","first-page":"2","article-title":"Screening extracts of Zanthoxylum chalybeum and Warburgia ugandensis for activity against measles virus (Swartz and Edmonston strains) in vitro","volume":"2","author":"Olila","year":"2002","journal-title":"Afr. Health Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s13337-014-0228-6","article-title":"In vitro anti-canine distemper virus activity of fucoidan extracted from the brown alga Cladosiphon okamuranus","volume":"25","year":"2014","journal-title":"Virus Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00705-011-1032-x","article-title":"In vivo evaluation of the antiviral activity of Cajanus cajan on measles virus","volume":"156","author":"Nwodo","year":"2011","journal-title":"Arch. Virol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1021\/np50024a015","article-title":"An investigation of the antiviral activity of Podophyllum peltatum","volume":"45","author":"Bedows","year":"1982","journal-title":"J. Nat. Prod."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0166-3542(93)90094-Y","article-title":"Antiviral traditional medicines against herpes simplex virus (HSV-1), poliovirus, and measles virus in vitro and their therapeutic efficacies for HSV-1 infection in mice","volume":"22","author":"Kurokawa","year":"1993","journal-title":"Antivir. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jep.2007.06.011","article-title":"Traditional dietary additives of the Maasai are antiviral against the measles virus","volume":"114","author":"Parker","year":"2007","journal-title":"J. Ethnopharmacol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4265\/bio.15.45","article-title":"Evaluation of the antiviral activity of chlorine dioxide and sodium hypochlorite against feline calicivirus, human influenza virus, measles virus, canine distemper virus, human herpesvirus, human adenovirus, canine adenovirus and canine parvovirus","volume":"15","author":"Sanekata","year":"2010","journal-title":"Biocontrol Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"313","DOI":"10.7164\/antibiotics.34.313","article-title":"Selective antiviral activity of the antibiotic 2\u2032-amino-2\u2032-deoxyribofuranosyl adenine","volume":"34","author":"Taguchi","year":"1981","journal-title":"J. Antibiot."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.peptides.2011.05.015","article-title":"Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses","volume":"32","author":"Li","year":"2011","journal-title":"Peptides"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1128\/am.16.10.1489-1496.1968","article-title":"Antiviral activity of carbobenzosy di- and tripeptides on measles virus","volume":"16","author":"Miller","year":"1968","journal-title":"Appl. Microbiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.virusres.2008.10.018","article-title":"Inhibition of measles virus infections in cell cultures by peptide-conjugated morpholino oligomers","volume":"140","author":"Sleeman","year":"2009","journal-title":"Virus Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000221862","article-title":"Antiviral activity of a pyrazino-pyrazine derivative","volume":"21","author":"Verini","year":"1975","journal-title":"Chemotherapy"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1099\/0022-1317-45-1-249","article-title":"Studies on antiviral glycosides, 4. Inhibition of the multiplication of paramyxoviruses by phenyl-6-chloro-6-deoxy-beta-D-glucopyranoside","volume":"45","author":"Sugita","year":"1979","journal-title":"J. Gen. Virol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1099\/jgv.0.001472","article-title":"A novel antiviral formulation inhibits a range of enveloped viruses","volume":"101","author":"Fletcher","year":"2020","journal-title":"J. Gen. Virol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00000441-197302000-00005","article-title":"Antiviral activity of isoprinosine in vitro and in vivo","volume":"265","author":"Chang","year":"1973","journal-title":"Am. J. Med. Sci."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"De Clercq, E., and Neyts, J. (2009). Antiviral agents acting as DNA or RNA chain terminators. Handbook of Experimental Pharmacology, Springer.","DOI":"10.1007\/978-3-540-79086-0_3"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.3390\/v7102868","article-title":"Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance","volume":"7","author":"Eltahla","year":"2015","journal-title":"Viruses"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1126\/science.177.4050.705","article-title":"Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide","volume":"177","author":"Sidwell","year":"1972","journal-title":"Science"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Geraghty, R.J., Aliota, M.T., and Bonnac, L.F. (2021). Broad-Spectrum Antiviral Strategies and Nucleoside Analogues. Viruses, 13.","DOI":"10.3390\/v13040667"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00705-004-0417-5","article-title":"RNA synthesis during infection by Hendra virus: An examination by quantitative real-time PCR of RNA accumulation, the effect of ribavirin and the attenuation of transcription","volume":"150","author":"Wright","year":"2005","journal-title":"Arch. Virol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S1286-4579(02)00008-4","article-title":"Implications of high RNA virus mutation rates: Lethal mutagenesis and the antiviral drug ribavirin","volume":"4","author":"Crotty","year":"2002","journal-title":"Microbes Infect."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e00221-18","DOI":"10.1128\/mBio.00221-18","article-title":"Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease","volume":"9","author":"Agostini","year":"2018","journal-title":"mBio"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"ref_97","unstructured":"Gilead (2022, February 20). Press Releases: U. S. Food and Drug Administration Approves Gilead\u2019s Antiviral Veklury (Remdesivir) for Treatment of COVID-19. Available online: https:\/\/www.gilead.com\/news-and-press\/press-room\/press-releases\/2020\/10\/us-food-and-drug-administration-approves-gileads-antiviral-veklury-remdesivir-for-treatment-of-covid19."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1039\/D0MD00318B","article-title":"Recent advances in the discovery of potent RNA-dependent RNA-polymerase (RdRp) inhibitors targeting viruses","volume":"12","author":"Kumar","year":"2021","journal-title":"RSC Med. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/1087057108321089","article-title":"High-throughput screening-based identification of paramyxovirus inhibitors","volume":"13","author":"Yoon","year":"2008","journal-title":"J. Biomol. Screen."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/eji.200939949","article-title":"Specific CD8(+) T-lymphocytes control dissemination of measles virus","volume":"40","author":"Osterhaus","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.chom.2014.06.007","article-title":"Antagonism of the phosphatase PP1 by the measles virus V protein is required for innate immune escape of MDA5","volume":"16","author":"Davis","year":"2014","journal-title":"Cell Host Microbe"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/JVI.02924-14","article-title":"Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates","volume":"89","author":"Rennick","year":"2015","journal-title":"J. Virol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1038\/s41467-018-07515-0","article-title":"Studies into the mechanism of measles-associated immune suppression during a measles outbreak in the Netherlands","volume":"9","author":"Laksono","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1080\/21645515.2019.1621148","article-title":"The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles","volume":"15","author":"Young","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_105","first-page":"202","article-title":"Use of Concentrated Human Serum Gamma-Globulin in the Prevention and Attenuation of Measles","volume":"21","author":"Janeway","year":"1945","journal-title":"Bull. N. Y. Acad. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1126\/science.abf4896","article-title":"Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets","volume":"371","author":"Schmitz","year":"2021","journal-title":"Science"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"9770","DOI":"10.1073\/pnas.91.21.9770","article-title":"Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection","volume":"91","author":"Wild","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_108","first-page":"S9","article-title":"Clinical safety and efficacy of enfuvirtide (T-20), a new fusion inhibitor. A review of the presentation at the satellite symposium \u201cNew hope: Advancing care in HIV infection\u201d at the 15th annual Association of Nurses in AIDS Care conference, November 2002","volume":"13","author":"Lalezari","year":"2003","journal-title":"AIDS Read."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jac\/dkh330","article-title":"Resistance to enfuvirtide, the first HIV fusion inhibitor","volume":"54","author":"Greenberg","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1128\/JVI.80.3.1524-1536.2006","article-title":"Two domains that control prefusion stability and transport competence of the measles virus fusion protein","volume":"80","author":"Doyle","year":"2006","journal-title":"J. Virol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1073\/pnas.0901007106","article-title":"Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency","volume":"106","author":"Ingallinella","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Porotto, M., Rockx, B., Yokoyama, C.C., Talekar, A., Devito, I., Palermo, L.M., Liu, J., Cortese, R., Lu, M., and Feldmann, H. (2010). Inhibition of Nipah virus infection in vivo: Targeting an early stage of paramyxovirus fusion activation during viral entry. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1001168"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"12579","DOI":"10.1128\/JVI.77.23.12579-12591.2003","article-title":"A ferret model of canine distemper virus virulence and immunosuppression","volume":"77","author":"Springfeld","year":"2003","journal-title":"J. Virol."},{"key":"ref_114","first-page":"89","article-title":"Current animal models: Cotton rat animal model","volume":"330","author":"Niewiesk","year":"2009","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1348-0421.1984.tb00731.x","article-title":"Slow development of measles virus (Edmonston strain) infection in the brain of nude mice","volume":"28","author":"Ohuchi","year":"1984","journal-title":"Microbiol. Immunol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1128\/AAC.38.4.653","article-title":"Effect of ribavirin on subacute sclerosing panencephalitis virus infections in hamsters","volume":"38","author":"Honda","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1128\/AAC.40.1.241","article-title":"Effective ribavirin concentration in hamster brains for antiviral chemotherapy for subacute sclerosing panencephalitis","volume":"40","author":"Ishii","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1128\/AAC.45.3.943-945.2001","article-title":"High-dose intravenous ribavirin therapy for subacute sclerosing panencephalitis","volume":"45","author":"Hosoya","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1128\/AAC.48.12.4631-4635.2004","article-title":"Pharmacokinetics and effects of ribavirin following intraventricular administration for treatment of subacute sclerosing panencephalitis","volume":"48","author":"Hosoya","year":"2004","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/6\/1186\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:20:57Z","timestamp":1760138457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/6\/1186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,29]]},"references-count":119,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["v14061186"],"URL":"https:\/\/doi.org\/10.3390\/v14061186","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,29]]}}}